Animal model of margosa oil ingestion with Reye-like syndrome. Pathogenesis of microvesicular fatty liver

Contributions to the phytotherapies of digestive disorders: Traditional knowledge and cultural drivers of Manoor Valley, Northern Pakistan

ETHNO PHARMACOLOGICAL RELEVANCE

Ethno medicinal traditional knowledge regarding the uses of indigenous medicinal plants used for various human digestive disorders are mostly known to the elder community members. As the young generation is not much aware about such vital traditional medicinal practice because they rely on elders.

AIM OF STUDY

To document, accumulate and widely disseminate the massive indigenous knowledge of century's practiced therapeutic uses of medicinal plants by the local people living in this remote area.

MATERIALS AND METHODS

A total of 63 local inhabitants (39 males and 24 females) were interviewed through a structured questionnaire. The data obtained were quantitatively analyzed through the use value (UV_i), fidelity level index (FL%) and relative frequency citations (RFCs), consensus index (CI%) and informant consensus factor (F_IC). For novel uses all the plants were checked with previously published articles on same disease by analyzing through Jaccard index (JI) and Sorensen's similarity index (QS). Plants specimen were preserved, mounted and labeled on the herbarium sheets, cataloged and deposited with voucher numbers in Hazara University Herbarium, Mansehra, Pakistan (HUP).

RESULTS

44 plant species belonging to 44 genera and 28 families were documented in the current study. These medicinal plant species were used commonly as an ethno medicine against 26 various digestive disorders out of which most frequently occurred are; stomach ache, diarrhea, indigestion, constipation and inflammation etc. Herbaceous plant species were the dominant among plants studied which were 64% of the total plants, followed by trees (20%) and shrubs (16%). Lamiaceae was the leading family among collected medicinal plant species (13.6%). Maximum medicinal plant species were used for treatment of stomach ache (11.7%), diarrhea and indigestion (10.9% each). Most widely used parts were leaves (41% citations), fruit and whole plant (12% citations each) for medication of various digestive problems by the traditional drivers. Dominated medicinal plants with most use values were Ficus carica having (UV_i=0.90) and Trifolium repens (UV_i=0.84). Based on the RFC values, the most cited medicinal plant species by the traditional drivers were Ficus carica (0.43) and Berberis lycium (0.41), while most respondents percentage was noticed for same plant species calculated through consensus index (CI%=42.9% and 41.3%) respectively. The medicinal plant species with highest fidelity level was of Grewia optiva, Juglans regia and Sorbaria tomentosa each cited 100% for anthelmintic, easy digestion and Diarrhea respectively. Due to representation by only single medicinal plant taxa (Nt=1), the digestive diseases viz. cholera, colon cancer, emetic, internal injuries, kill microorganisms, Soothing, tumor and urine suppression had maximum F_IC value. The analytical result reveals that 57% of medicinal plant species were reported for the first time regarding their uses. new medicinal uses of Anaphalis contorta, Caltha palustris, Pinus wallichiana, Plantago himalaica were recorded for the first time from Pakistan and Aralia cachemirica, Bupleurum longicaule, Pleurospermum stellatum, Potentilla argentea and Juglans regia across the globe for currently reported medicinal uses. Besides this, all the mentioned plant species were reported for the first time for digestive disorders from Manoor Valley as no single study up-till now has been conducted ethno medicinally.

CONCLUSION

The present study revealed the importance to document and launch list of all the possible plants that are used in traditional medicinal practices against digestive disorders in the unexplored study area and to show the important medicinal plants for future biological, phytochemical and pharmacological experimentation regarding digestive problems.

Toxicological evaluation of neem (Azadirachta indica) oil: acute and subacute toxicity

Neem (Azadirachta indica), popularly known as traditional medicine is a native plant in India. Neem oil is a vegetable oil derived from seeds or fruits of the neem tree through pressing or solvent extraction, and largely used in popular medicine to have antifungal, antibacterial, antimalarial, antiparasitic, anti-inflammatory, as well as immunemodulatory properties in different animal species. In the present study, acute and 28-day subacute toxicity tests were carried out. In the acute toxicity test, the LD50 values of neem oil were found to be 31.95g/kg. The subacute treatment with neem oil failed to change body weight gain, food and water consumption. Serum biochemistry analysis showed no significant differences in any of the parameters examined under the dose of 1600mg/kg/day. Histopathological exams showed that the target organs of neem oil were testicle, liver and kidneys up to the dose of 1600mg/kg/day.

Herbal medicine: a survey of use in Nigerian presurgical patients booked for ambulatory anaesthesia

BACKGROUND

Utilization of herbal medicines in the preoperative period by Nigerian patients booked for day case surgery has not been explored.

METHODS

Cross-sectional survey of 60 patients presenting for day-case surgery at a tertiary healthcare institution over a 3-week period in August 2011 was conducted. Using a structured questionnaire, inquiries were made concerning use of herbal medicines in the immediate preoperative period. Socio-demographic characteristics, information on use of concurrent medical prescriptions, types of herbs used, reasons for use, perceived side effects and perceived efficacy were obtained. Data were evaluated using descriptive statistics and Chi-square.

RESULTS

Fifty-two (86.7%) were American Society of Anesthesiologists (ASA) class 1 while 8 (13%) were ASA 2. Most patients (86.7%) had their procedures done under local infiltration with monitored anaesthesia care (MAC), while 5.0% and 8.3% had their procedures done under regional and general anaesthesia, respectively. About 48.3% of respondents were on concurrent medical prescriptions while 51.7% were not. Forty percent (40%) of patients admitted to use of herbal medicine, all by the oral route, in the immediate perioperative period; 87.5% did not inform their doctor of their herbal use. Types of herbs used included 'dogonyaro', 'agbo', 'nchanwu', and Tahitian noni. Treatment of malaria was commonest reason for use in 29.2% of patients, while cough and concurrent surgical condition were reasons given by 12.5% of patients, respectively. Seventy-nine percent (79.2%) of patients considered their herbal medications effective. Perceived side effects of herbal medication (16.6%) included fever, waist pain and intoxication. There were no variations in use between ASA 1 and ASA 2 patients and none between respondents on conventional medication against those that were not. Variables such as age less than 35 years, female gender, being married and being an urban dweller did not show any significant difference in use.

CONCLUSION

This survey revealed many patients were on one or more herbal preparations in the immediate preoperative period. In consideration of possible untoward drug interactions between conventional medication, herbal preparations and anaesthesia, doctors (especially anaesthetists) should routinely assess all patients booked to be anaesthetized, especially those for day case surgery. The authors recommend surveys with larger respondent numbers to determine prevalence of use and possible interactions between indigenous Nigerian herbs and anaesthesia.

Hepatotoxicity associated with herbal products

A significant number of herbal products have been associated with hepatotoxicity. Attribution of liver injury to a specific herbal pro-duct may be difficult. There are few clinical or laboratory manifestations that specifically suggest that liver injury is the result of aspecific herbal. Compounding this difficulty is that the patient may have liver disease from another cause, may be consuming other potentially hepatotoxic products, or may be using a contaminated herbal product. The most important clue often is the temporal relationship between initiation of the herbal product and the appearance of liver injury; of equal importance is the resolution of the injury following withdrawal of the herbal product.

Two formulations of the industrial surfactant, Toximul, differentially reduce mouse weight gain and hepatic glycogen in vivo during early development: effects of exposure to Influenza B Virus

Previous studies demonstrated that young mice exposed chronically to industrial surfactant (IS) do not exhibit obvious adverse health effects, but do have persistently reduced body weights and compromised hepatic energy metabolism. The present study examined the time course of effects of two formulations of the Toximul (Tox) class of anionic/nonionic IS on body weights and liver glycogen (+/-virus) during early development. Results showed that effects differed in two commonly used strains of mice. In CFW mice, 12 days' exposure to Tox resulted in retardation of weight gain that was most obvious several days after exposure ceased. In this strain effects were greater with Tox 3409F than with Tox MP-A and appeared to be reversible except when the mice were treated with both Tox 3409F and FluB. Weights of the CD-1 mice were not affected by either Tox treatment alone, but were significantly reduced on postnatal day 20 when Tox exposure had been combined with FluB infection. Postnatal replenishment of hepatic glycogen stores during the first three weeks also occurred at different rates in CFW and CD-1 mice. The effects of Tox (+/-FluB) on glycogen also varied with mouse strain and Tox formulation. In CFW mice, exposure to either formulation resulted in significant (55-59%) reductions in glycogen, although reductions were not evident until nine days after Tox exposure stopped. By contrast, hepatic glycogen in CD-1 mice was reduced both during and after dermal exposure to Tox 3409F, whereas no effect was observed with Tox MP-A. Notably, the 3409F effect was reversible in the CD-1 mice, but reversal did not occur in mice also infected with FluB. Tox MP-A+FluB-treated mice exhibited only a transient glycogen reduction. These results illustrate the importance of mouse strain and formulation specificities in assessing biological effects of xenobiotic surfactants. As well, they emphasize that chronic IS exposure can induce changes in growth and energy substrate availability in young mice that may not be evident unless there is a precipitating cofactor such as a viral infection.

Caprine hepatic lipidosis induced through the intake of low levels of dietary cobalt

Forty-one, 10-week-old newly weaned goats were randomly allocated into two groups, namely control (n=22) and treated (n=19). Kids in both groups were fed Rhodegrass hay ad libitum that contained < 0.1 mg/kg DM cobalt and 150 g/day of a commercially prepared ruminant concentrate that contained approximately 0.12 mg/kg DM cobalt. This diet provided the minimum daily requirement of cobalt as specified for sheep. The treated goats were supplemented with bi-monthly subcutaneous injections of 2000 microg of hydroxycobalamin. All goats were weighed and blood samples collected monthly for haematological, clinical biochemical and serum vitamin B12 analysis. After a 10-month experimental period the goats were slaughtered. The control animals exhibited significantly (P<0.05) lower weight gains, and had dry scruffy hair coats. In addition, there was a decline in erythrocyte counts, mean haemoglobin, packed cell volume, mean corpuscular volume, mean corpuscular haemoglobin and mean corpuscular haemoglobin concentration. Controls also exhibited significantly (P<0.05) lower levels of total serum proteins and elevated levels of serum alkaline phosphatase compared to treated goats. Fourteen (63.6%) of the control goats developed pathology consistent with reported field cases of hepatic lipidosis associated with low liver levels of cobalt. Only one (5.3%) of the treated goats developed hepatic lipidosis. Contrary to previous reports that suggested that goats are less sensitive to low levels of dietary cobalt than sheep, it is apparent that this is not the case with Omani goats. This is the first report of the induction of hepatic lipidosis in goats due to feeding low levels of cobalt in their diet.

An abattoir survey of caprine liver diseases in the sultanate of Oman

The examination of 675 caprine livers from a slaughterhouse in the Greater Muscat area in the Sultanate of Oman revealed that 63 (9.3%) exhibited gross pathological changes leading to condemnation of this organ. Forty of these livers (71.4%) exhibited one major abnormality, whereas the remaining 28.6% had two or more lesions. The most frequently occurring disorder was diffuse hepatic lipidosis (4.0%), followed by bacterial associated abscesses (2.4%), cysticercosis (1.9%), and eosinophilic granulomata (1%). Although the cause for the hepatic lipidosis was not determined it appeared to be a reversible condition based on the absence of degenerative nuclei within the affected hepatocytes. Conditions observed in only a single liver were subcapsular (non-parasitic) cysts, focal necrosis, micronodular cirrhosis, extensive bile duct proliferation and diffuse haemorrhage.

Acute and reversible fatty metamorphosis of cultured rat hepatocytes

Rat hepatocyte cell line M6, B347 and J525, among which only M6 is slightly deviated from diploidy, showed marked microvesicular fatty metamorphosis in response to treatment with Tweens at concentrations of 0.05-0.025% in Eagle's minimum essential medium (MEM). Within 24 h treated cells became fatty at 100% in frequency and filled with small lipid droplets, as revealed by fat staining or at the ultrastructural level. Fatty hepatocytes, however, took again non-fatty morphology 72 h after withdrawal of Tweens from the culture medium. Growth of the cell exhibited mild retardation at the early phase of the treatment but almost similar cell density to that of control cells was achieved 24 h after the treatment. Other detergents without fatty-acid moiety, including NP-40, triton X-100, sodium deoxycholic acid and sodium cholic acid, were ineffective to induce fatty change. Oleate, a fatty-acid moiety of Tween 80 or 85, and linolate caused reversible fatty metamorphosis of the cell lines at concentrations of 1.9 x 10(4) mol/L or more and 3.8 x 10(4) mol/L or more, respectively. Ethanol induced mild steatosis of the cell lines and enhanced fatty change by linolate. Hepatic fatty acid-binding protein was not detected in the cell lines before or after the induction of fatty change. These results indicate that fatty acid itself is directly incorporated in cultured rat hepatocytes and expelled 3 days later without apparent cell degeneration.